Kevin Rockich

577 total citations
22 papers, 422 citations indexed

About

Kevin Rockich is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Kevin Rockich has authored 22 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Kevin Rockich's work include Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Kevin Rockich is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Kevin Rockich collaborates with scholars based in United States, France and United Kingdom. Kevin Rockich's co-authors include Robert A. Blouin, Claudia Sommerer, Lorraine C. Racusen, Marc E. Uknis, T. Shah, David Fitts, E. Steve Woodle, Robert A. Montgomery, Babak J. Orandi and Jacqueline Garonzik‐Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Kevin Rockich

21 papers receiving 411 citations

Peers

Countries citing papers authored by Kevin Rockich

Since Specialization

Citations

This map shows the geographic impact of Kevin Rockich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Rockich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Rockich more than expected).

Fields of papers citing papers by Kevin Rockich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Rockich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Rockich. The network helps show where Kevin Rockich may publish in the future.

Co-authorship network of co-authors of Kevin Rockich

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Rockich. A scholar is included among the top collaborators of Kevin Rockich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Rockich. Kevin Rockich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Itraconazole or Rifampin on Zilurgisertib Pharmacokinetics When Administered Orally in Healthy Participants 2025 ·Clinical Pharmacology in Drug Development ·Yue Yang, Xiaohua Gong, (unknown), Xiang Liu, (unknown), Jennifer Sheng, Swamy Yeleswaram, Xuejun Chen, Kevin Rockich	0
2	Pharmacokinetics of Zilurgisertib With and Without Food from Single and Multiple Ascending Dose Phase 1 Studies in Healthy Adults 2024 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), Xiaohua Gong, (unknown), (unknown), Xiang Liu, Jennifer Sheng, (unknown), Kevin Rockich	1
3	Effects of Cimetidine and Dolutegravir on the Endogenous Drug–Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers 2024 ·Clinical Pharmacology & Therapeutics ·(unknown), (unknown), Kunal S. Taskar, Maciej J. Zamek‐Gliszczynski, Kenta Yoshida, Xiaoyan Chu, (unknown), (unknown), Kevin Rockich, Tadayuki Takashima, Yoshiyuki Yamaura, Yurong Lai, (unknown), (unknown), Kazuya Maeda, Kenichi Furihata, Yuichi Sugiyama, Hiroyuki Kusuhara	7
4	Physiologically‐based pharmacokinetic model‐based translation of OATP1B‐mediated drug–drug interactions from coproporphyrin I to probe drugs 2022 ·Clinical and Translational Science ·Tatsuki Mochizuki, Yasunori Aoki, Takashi Yoshikado, Kenta Yoshida, Yurong Lai, Hideki Hirabayashi, Yoshiyuki Yamaura, Kevin Rockich, Kunal S. Taskar, Tadayuki Takashima, Xiaoyan Chu, Maciej J. Zamek‐Gliszczynski, (unknown), Kazuya Maeda, Kenichi Furihata, Yuichi Sugiyama, Hiroyuki Kusuhara	24
5	Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions 2022 ·Clinical Pharmacology & Therapeutics ·Tatsuki Mochizuki, Maciej J. Zamek‐Gliszczynski, Kenta Yoshida, (unknown), Kunal S. Taskar, Hideki Hirabayashi, Xiaoyan Chu, Yurong Lai, Tadayuki Takashima, Kevin Rockich, Yoshiyuki Yamaura, (unknown), Tadahaya Mizuno, Kazuya Maeda, Kenichi Furihata, Yuichi Sugiyama, Hiroyuki Kusuhara	27
6	Evaluation of drug-drug interactions of pemigatinib in healthy participants 2021 ·European Journal of Clinical Pharmacology ·Tao Ji, Kevin Rockich, (unknown), (unknown), Phillip Wang, Xuejun Chen, Naresh Punwani, Swamy Yeleswaram	13
7	Effect of Hepatic Impairment on the Pharmacokinetics of Itacitinib 2021 ·The Journal of Clinical Pharmacology ·April Barbour, Kevin Rockich, (unknown), Gongfu Zhou, (unknown), Xuejun Chen, Swamy Yeleswaram, (unknown), Naresh Punwani	2
8	Evaluation of the pharmacokinetics of pemigatinib in patients with impaired hepatic or renal function 2021 ·British Journal of Clinical Pharmacology ·Tao Ji, Kevin Rockich, (unknown), (unknown), Phillip Wang, Xuejun Chen, Naresh Punwani, Swamy Yeleswaram	12
9	An Open‐Label Study to Assess the Effect of Itraconazole and Rifampin on Parsaclisib Pharmacokinetics When Administered Orally in Healthy Participants 2020 ·The Journal of Clinical Pharmacology ·Jia Li, Kevin Rockich, (unknown), Gongfu Zhou, (unknown), Naresh Punwani, Xuejun Chen, Swamy Yeleswaram	9
10	Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study 2016 ·American Journal of Transplantation ·Robert A. Montgomery, Babak J. Orandi, Lorraine C. Racusen, Annette M. Jackson, Jacqueline Garonzik‐Wang, T. Shah, E. Steve Woodle, Claudia Sommerer, David Fitts, Kevin Rockich, (unknown), Marc E. Uknis	120
11	Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study 2016 ·European Journal of Endocrinology ·Gudmundur Johannsson, Hans Lennernäs, Claudio Marelli, Kevin Rockich, Stanko Skrtic	21
12	Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema 2016 ·Allergy and Asthma Proceedings ·Marc A. Riedl, William R. Lumry, (unknown), Aleena Banerji, Jonathan A. Bernstein, Murat Baş, Janne Björkander, Markus Magerl, Marcus Maurer, Kevin Rockich, (unknown), Jennifer Schranz	10
13	Phase I Safety and Pharmacokinetic Study of the PI3K/mTOR Inhibitor SAR245409 (XL765) in Combination with Erlotinib in Patients with Advanced Solid Tumors 2014 ·Journal of Thoracic Oncology ·Pasi A. Jänne, Roger B. Cohen, Alexander Laird, Sandrine Macé, Jeffrey A. Engelman, Rodrigo Ruiz-Soto, Kevin Rockich, Jianbo Xu, Geoffrey I. Shapiro, Pablo Martínez, Enriqueta Felip	39
14	Tumor pharmacokinetics (PK) and pharmacodynamics (PD) of SAR245409 (XL765) and SAR245408 (XL147) administered as single agents to patients with recurrent glioblastoma (GBM): An Ivy Foundation early-phase clinical trials consortium study. 2013 ·Journal of Clinical Oncology ·Timothy F. Cloughesy, Paul S. Mischel, Antonio Omuro, Michael D. Prados, Patrick Y. Wen, (unknown), Kevin Rockich, (unknown), Joanne Lager, Ingo K. Mellinghoff	18
15	Phase I Trial of SAR245408 (S08), a Pan-Phosphatidylinositol 3 Kinase (PI3K) Inhibitor, in Patients with Chronic Lymphocytic Leukemia (CLL) and Lymphoma 2011 ·Blood ·Jennifer R. Brown, Matthew S. Davids, Jordi Rodón, Pau Abrisqueta, Arthur P. DeCillis, Kevin Rockich, Coumaran Égile, (unknown), Yi Xu, Joanne Lager, Farrukh T. Awan	10
16	A Phase I Dose Expansion Cohort Study of the Safety, Pharmacokinetics and Pharmacodynamics of SAR245409 (S09), An Orally Administered PI3K/mTOR Inhibitor, in Patients with Lymphoma 2011 ·Blood ·Kyriakos P. Papadopoulos, Pau Abrisqueta, (unknown), (unknown), Amita Patnaik, Josep Tabernero, Kanya Rajangam, Kevin Rockich, Coumaran Égile, (unknown), (unknown), Joanne Lager, Julie M. Vose	11
17	Abstract A134: Pharmacokinetics and metabolism of iniparib for the treatment of metastatic triple-negative breast cancer (TNBC). 2011 ·Molecular Cancer Therapeutics ·Jaap Verweij, Véronique Dièras, Kevin Rockich, Yaming Su, D. Méry-Mignard, (unknown), (unknown)	2
18	Pre- or post-treatment with the mitochondrial uncoupler 2,4-dinitrophenol attenuates striatal quinolinate lesions 2003 ·Brain Research ·William F. Maragos, Kevin Rockich, (unknown), Kristie L. Young	33
19	Effect of Recombinant Human Growth Hormone and Insulin‐Like Growth Factor‐1 Administration on IGF‐1 and IGF‐Binding Protein‐3 Levels in Brain Injury 1999 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Kevin Rockich, Jimmi Hatton, Richard J. Kryscio, Byron Young, Robert A. Blouin	10
20	Effect of the Acute-Phase Response on the Pharmacokinetics of Chlorzoxazone and Cytochrome P-450 2E1 In Vitro Activity in Rats 1999 ·Drug Metabolism and Disposition ·Kevin Rockich, Robert A. Blouin	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact